HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HBW Podcasts

Listen to HBW Insight podcasts for our perspectives on regulation, policy, quality, R&D and key commercial topics.

Over The Counter 26 Sept 2023: Disrupting the Consumer Health Industry, With Maxwellia’s Anna Maxwell

In this episode, HBW Insight catches up with UK switch specialists Maxwellia to find out what’s next for the company that gave to the UK one of the first OTC daily contraceptive pills. Now a disruptive consumer health player in its own right, the company is looking for investors to take it to the next level and help launch two new women’s health products in the pipeline for next year, CEO Anna Maxwell reveals in this exclusive interview.

Over The Counter 11 Sept 2023: Trends Shaping The OTC Industry Today, With BSS Consulting’s Birgit Schuhbauer

In the second part of HBW Insight’s exclusive interview with OTC industry veteran Birgit Schuhbauer, we discuss the trends that will shape the future of consumer health. Drawing on her extensive experience in OTC, most recently as global vice president of J&J’s Self Care franchise and president of the AESGP, Schuhbauer gives her views on consumer shifts towards self-care and prevention, digitalization and e-commerce, supply chain resilience and sustainability. Schuhbauer also offers an insiders perspective on moves by companies like Kenvue and Haleon to spin out as independent OTC players, and the implications for Rx-to-OTC switch.

Over The Counter 29 Aug 2023: How To Be A Consumer Health Leader, With BSS Consulting’s Birgit Schuhbauer

In this episode, HBW Insight talks to BSS Consulting’s Birgit Schuhbauer about her stellar career in consumer health. Until recently, Schuhbauer was global vice president of Johnson & Johnson’s Self Care franchise and president of the Association of the European Self-Care Industry. Now running her own consulting business, Schuhbauer reflects in this first part of a two-part exclusive interview on her career highlights, what it takes to be a leader in OTC and on her role as the AESGP’s first female president during a time of unprecedented change.

Over The Counter Special: OTC Marketing Awards Judge On What Makes A Standout Entry, With PAGB's Michelle Riddalls

In this special podcast episode, we speak to PAGB CEO Michelle Riddalls about her role as an OTC Marketing Awards judge and what makes a good entry in her extensive experience. Having spent two decades working in some of the world's largest OTC companies, and now heading up the UK’s OTC industry association which plays an important role in reviewing members' marketing campaigns before they go live, Riddalls is well placed to offer advice to companies working on their entries. Making submissions UK-specific, data-driven but also inclusive of all the creativity that teams bring to a launch or campaign are some of the pointers Riddalls shares with us. Friday 1 September is the entry deadline for the 2023 Awards, which take place at the Royal Lancaster London on Thursday 23 November. If you are interested in entering, head over to Citeline’s 2023 UK OTC Marketing Awards website.

Over The Counter 7 Aug 2023: What Happens To Software As A Medical Device Under The EU AI Act? With Bristows’ Jamie Hatzel

In the second part of HBW Insight’s interview with Bristows' digital health regulatory expert Jamie Hatzel, we talk about artificial intelligence. Hatzel discusses what happens to Software as a Medical Device within the incoming EU artificial intelligence legislation, which has now entered trilogue negotiations. Issues such as the meaning of “high risk” within the proposed AI Act, in contrast to its meaning in the existing Medical Device Regulations, highlight the importance for manufacturers in this space, or thinking about entering it, of getting good advice, Hatzel points out.

Over The Counter 24 July 2023: What Is ‘Software As A Medical Device’ And How Is It Regulated In Europe? With Bristows’ Jamie Hatzel

Digitalization is a hot topic in consumer health, and “digital health” covers a broad spectrum of applications, from wellness apps to virtual reality therapeutics. In this episode of Over The Counter, HBW Insight speaks to Jamie Hatzel, regulatory associate at law firm Bristows, to get some clarity on “software as a medical device” – a subset of medical device regulatory frameworks within which many digital health applications are classified. In the first part of a two-part podcast, Hatzel outlines the UK and EU regulatory approaches to SaMDs, before we discuss specific examples such as symptom trackers, wellness apps and digital therapeutics.

Over The Counter 10 July 2023: Prescription Slimming Drugs And Their OTC Alternatives, With OptiBiotix’s Stephen O’Hara

In this episode, we explore recent consumer interest in prescription weight loss drugs such as Novo Nordisk's Wegovy with gut health expert Stephen O’Hara. As CEO of microbiome specialist OptiBiotix Health, O’Hara points to over-the-counter alternatives like prebiotic food supplements and medical devices, which may offer similar hunger-reducing benefits without the side effects associated with these drugs. By successfully negotiating health claim regulations, as well as investing in new markets and in new delivery formats like gummies, companies like Optibiotix are looking to take advantage of this new interest in slimming solutions, he explains.

What You Need To Know About The EU Green Claims Directive, With PHD’s Jo Stephenson

In this episode, HBW Insight looks at yet another piece of EU sustainability legislation, this time the Green Claims Code. Sustainability expert Jo Stephenson, managing director of PHD Marketing, explains the background to the legislation, which proposes detailed rules for companies that wish to make environmental claims. Although companies are not required to make green claims, and may choose not to given these stricter rules, Stephenson points out that companies will soon be required to record and report extensive environmental data, so may as well use this information to create robust and credible green claims. Being used to strict rules on making health claims, consumer healthcare firms are in a good position to embrace and even benefit from this new framework, Stephenson also points out.


Citeline podcasts discuss key ideas and insights affecting biopharma and medtech, brought to you by our global team of editors. Listen on-demand to our perspectives on the latest industry developments.